Today I breakdown Zafgen's problematic history with an update on their newest generation of MetAP2 inhibitors for treatment of Type 2 Diabetes. I also talk about Tandem Diabetes Care and their latest FDA approval. Follow me on twitter @matthewlepoire Relevant links: http://zafgen.gcs-web.com/news-releases/news-release-details/zafgen-announces-positive-full-results-phase-2-proof-concept http://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-diabetes-care-announces-fda-approval-tslim-x2-insulin This is not investment advice